Extracellular BCL2 Proteins Are Danger-Associated Molecular Patterns That Reduce Tissue Damage in Murine Models of Ischemia-Reperfusion Injury
Authors:
Open Access
- 8 February 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (2) , e9103
Abstract
Ischemia-reperfusion (I/R) injury contributes to organ dysfunction in a variety of clinical disorders, including myocardial infarction, stroke, organ transplantation, and hemorrhagic shock. Recent investigations have demonstrated that apoptosis as an important mechanism of cell death leading to organ dysfunction following I/R. Intracellular danger-associated molecular patterns (DAMPs) released during cell death can activate cytoprotective responses by engaging receptors of the innate immune system. Ischemia was induced in the mouse hind limb by tourniquet or in the heart by coronary artery ligation. Reperfusion injury of skeletal or cardiac muscle was markedly reduced by intraperitoneal or subcutaneous injection of recombinant human (rh)BCL2 protein or rhBCL2-related protein A1 (BCL2A1) (50 ng/g) given prior to ischemia or at the time of reperfusion. The cytoprotective activity of extracellular rhBCL2 or rhBCL2A1 protein was mapped to the BH4 domain, as treatment with a mutant BCL2 protein lacking the BH4 domain was not protective, whereas peptides derived from the BH4 domain of BCL2 or the BH4-like domain of BCL2A1 were. Protection by extracellular rhBCL2 or rhBCL2A1 was associated with a reduction in apoptosis in skeletal and cardiac muscle following I/R, concomitant with increased expression of endogenous mouse BCL2 (mBCL2) protein. Notably, treatment with rhBCL2A1 protein did not protect mice deficient in toll-like receptor-2 (TLR2) or the adaptor protein, myeloid differentiation factor-88 (MyD88). Treatment with cytokine-like doses of rhBCL2 or rhBCL2A1 protein or BH4-domain peptides reduces apoptosis and tissue injury following I/R by a TLR2-MyD88-dependent mechanism. These findings establish a novel extracellular cytoprotective activity of BCL2 BH4-domain proteins as potent cytoprotective DAMPs.Keywords
This publication has 60 references indexed in Scilit:
- Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligandsNature Immunology, 2009
- Mal connects TLR2 to PI3Kinase activation and phagocyte polarizationThe EMBO Journal, 2009
- Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in miceBrain Research, 2009
- Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense functionProceedings of the National Academy of Sciences, 2008
- Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injuryJournal of Neuroimmunology, 2008
- Bcl-2–family proteins and hematologic malignancies: history and future prospectsBlood, 2008
- How dying cells alert the immune system to dangerNature Reviews Immunology, 2008
- Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findingsClinical and Experimental Immunology, 2006
- Evaluation of apoptosis in cerebrospinal fluid of patients with severe head injuryActa Neurochirurgica, 2006
- The Domains of Apoptosis: A Genomics PerspectiveScience's STKE, 2004